Pediatric Dosing Recommended dosage for children may vary based on different medical conditions: For the initial treatment of pernicious anemia, the usual dose is 30-50mcg SC/IM, given every day for 2 weeks, followed by maintenance treatment
IV Therapy Support: Used as a solvent for intravenous administration and compounding of injectable medications
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
This phase requires consistency above all else
Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol)
Cyanocobalamin is more commonly found in oral supplements and fortified foods, and while it is effective for many people, some practitioners prefer hydroxocobalamin for injections due to its natural form and longer retention
